Indication

Pediatric Acute-Onset Neuropsychiatric Syndrome

1 clinical trial

1 product

Clinical trial

A Superiority Phase III Study To Compare The Effect of Panzyga Versus Placebo in Patients With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS/PANDAS)

Status: Terminated, Estimated PCD: 2024-05-29

Product